Indapta Therapeutics

IN THE PRESS

Drug Development

Indapta Therapeutics Announces New Preclinical Data Demonstrating Proprietary G-NK Cells Enhance Efficacy of Monoclonal Antibodies in Multiple Myeloma

August 10, 2021

·

5 min read

Business

Indapta Therapeutics Announces Key Management Team Appointments to Advance into Clinical Trials in 2021

February 3, 2021

·

6 min read

Business

Multiple Myeloma Research Foundation (MMRF) and Indapta Therapeutics Announce Investment to Advance Clinical Development of Natural Killer Cell Therapy

October 28, 2020

·

4 min read

Business

Indapta Therapeutics Appoints Dov Goldstein, M.D., Chief Financial and Business Officer

August 31, 2020

·

4 min read

Biotech Bay

Indapta Therapeutics Provides Corporate Update

July 9, 2020

·

4 min read

Business

Indapta Therapeutics and Lonza Announce Strategic Partnership to Advance a Next-generation, Off-the-shelf, Allogeneic Immuno-oncology Therapy

January 10, 2020

·

11 min read

JOBS